Neighbourly Pharmacy (TSX:NBLY): Top Healthcare Stock for Q3 2022

A healthcare stock with defensive properties and excellent growth prospects should be an interesting buy in Q3 2022.

| More on:
supplements vitamins pills

Image source: Getty Images

The TSX’s healthcare sector has been a perennial underperformer. The primary reason it lacks excitement since 2020 is because of cannabis stocks. Thus far this year, the sector is the worst performer (-44.1%). However, a non-cannabis producer like Neighbourly Pharmacy (TSX:NBLY) is an interesting growth stock pick for Q3 2022.

The strong Q4 and full-year fiscal 2022 results promise tremendous growth potential and massive returns for would-be investors. At $24.43 per share, this healthcare stock trades at a deep discount. Its 52-week high is $40.07.  

Despite the year-to-date loss of 38.74%, market analysts covering the stock see an upside potential between 36.9% and 71.9% in 12 months. The overall return should be higher if you include the 0.66% dividend.

Successful IPO

Neighbourly Pharmacy went public on May 25, 2021, and generated nearly $200 million in proceeds from the IPO. The $841.15 million company acquires independent pharmacies and promote drugstores as primary healthcare hubs for communities.   

The growth of its network (+29.5%) is fast, given the present store count of 171 from 132 last year. Paul Gardner from Avenue Investment Management is extremely bullish on the pharmacy network consolidator. He said the healthcare stock has defensive properties because of the nature of the business. Customers visit drugstores daily to buy medicines and for other medical care services.

Financial highlights

In fiscal 2022 (12 months ended March 26, 2022), total revenue increased 39.5% to $427.5 million versus fiscal 2021 on a 3.1% year-over-year same-store sales growth. According to management, the financial results were impressive, considering the impact of the virulent Omicron variant and staffing shortages that persisted until the end of fiscal 2022.

Chris Gardner, CEO of Neighbourly Pharmacy, said, “Since our IPO, we have nearly doubled in size, and looking forward to fiscal 2023. The strength and essential nature of our business, our financial flexibility and strong EBITDA growth position us well to pursue our robust pipeline of acquisitions to continue to drive future growth.”

The next growth driver

On June 28, 2022, Neighbourly Pharmacy announced the complete acquisition of Rubicon Pharmacies for $435 million. Gardner said, “This acquisition represents a combination of Canada’s community pharmacy leaders. Rubicon’s locations are ideally positioned to expand Neighbourly’s presence from Manitoba to British Columbia, providing us with a significant and complementary footprint.”

Like Neighbourly, Rubicon pharmacies are present in rural, underserved communities where they act as centres of healthcare delivery. Management will integrate Rubicon’s pharmacies into its network to establish itself at scale with the 275 additional locations.

In March 2022, Chelsea Stellick, an analyst at IA Capital Markets, said, “Neighbourly’s acquisition of Rubicon Pharmacies aligns with management’s superb track record of aggressive expansion without compromising on and executing on only the most complementary deals.” She added that there are thousands more stores for Neighbourly to acquire in Canada.

Compelling opportunities

Gardner revealed that the company has already exceeded its historical pace of acquisition. Nevertheless, he believes that the Canadian pharmacy landscape continues to offer a robust pipeline of compelling opportunities. Neighbourly will proceed with the execution of its growth strategy.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Christopher Liew has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned.

More on Investing

Question marks in a pile
Bank Stocks

Should You Buy Canadian Western Bank for its 4.8% Dividend Yield?

Down 35% from all-time highs, Canadian Western Bank offers a tasty dividend yield of 4.8%. Is the TSX bank stock…

Read more »

Gold bars
Metals and Mining Stocks

Why Alamos Gold Jumped 7% on Wednesday

Alamos (TSX:AGI) stock and Argonaut Gold (TSX:AR) surged after the companies announced a friendly acquisition for $325 million.

Read more »

tsx today
Stock Market

TSX Today: Why Record-Breaking Rally Could Extend on Thursday, March 28

The main TSX index closed above the 22,000 level for the first time yesterday and remains on track to post…

Read more »

Nuclear power station cooling tower
Metals and Mining Stocks

If You’d Invested $1,000 in Cameco Stock 5 Years Ago, This Is How Much You’d Have Now

Cameco (TSX:CCO) stock still looks undervalued, despite a 258% rally. Can the uranium miner deliver more capital gains to shareholders?

Read more »

Businessman holding tablet and showing a growing virtual hologram of statistics, graph and chart with arrow up on dark background. Stock market. Business growth, planning and strategy concept
Dividend Stocks

TFSA Magic: Earn Enormous Passive Income That the CRA Can’t Touch

If you're seeking out passive income, with zero taxes involved, then get on board with a TFSA and this portfolio…

Read more »

potted green plant grows up in arrow shape
Stocks for Beginners

3 Growth Stocks I’m Buying in April

These three growth stocks are up in the last year, and that is likely to continue on as we keep…

Read more »

clock time
Tech Stocks

Long-Term Investing: 3 Top Canadian Stocks You Can Buy for Under $20 a Share

These three under-$20 stocks offer excellent buying opportunities for long-term investors.

Read more »

Man with no money. Businessman holding empty wallet
Dividend Stocks

2 Stocks Under $50 New Investors Can Confidently Buy

There are some great stocks under $50 that every investor needs to know about. Here’s a look at two great…

Read more »